Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
13.61
+0.11 (0.81%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Viridian Therapeutics Employees
Viridian Therapeutics had 252 employees as of December 31, 2025. The number of employees increased by 109 or 76.22% compared to the previous year.
Employees
252
Change (1Y)
109
Growth (1Y)
76.22%
Revenue / Employee
$281,147
Profits / Employee
-$1,118,762
Market Cap
1.40B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Agios Pharmaceuticals | 540 |
| Immunocore Holdings | 524 |
| Ardelyx | 489 |
| Wave Life Sciences | 317 |
| Biohaven | 274 |
| Precigen | 160 |
| Maze Therapeutics | 141 |
VRDN News
- 22 days ago - Why Is Viridian Therapeutics Stock Sinking Monday? - Benzinga
- 22 days ago - Viridian Therapeutics Stock Is Tanking. Why the Drop Is Linked to This Amgen Study. - Barrons
- 4 weeks ago - Why Is Viridian Therapeutics Stock Falling Monday? - Benzinga
- 4 weeks ago - Viridian Therapeutics Transcript: Study result - Transcripts
- 4 weeks ago - Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL‑1 Clinical Trial in Active Thyroid Eye Disease - Business Wire
- 7 weeks ago - Viridian Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Viridian Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire